Schizophrenia: Do we really need placebo-controlled studies?

Author： Storosum J.G.   Elferink A.J.A.   van Zwieten B.J.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.8, Iss.4, 1998-12, pp. : 279-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The failure of placebo-controlled studies

By Montgomery S.A.  

European Neuropsychopharmacology, Vol. 9, Iss. 3, 1999-03 ,pp. : 271-276

Elsevier

Access to resources Recommend Favorite

A placebo-controlled study of sildenafil effects on cognition in schizophrenia

By Goff Donald   Cather Corinne   Freudenreich Oliver   Henderson David   Evins A.   Culhane Melissa   Walsh Jared  

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 411-417

Springer Publishing Company

Access to resources Recommend Favorite

Do We Really Need to Keep Redesigning β2-agonists for the Management of Asthma?

By  

Current Drug Delivery, Vol. 12, Iss. 1, 2015-02 ,pp. : 9-15

Bentham Science Publishers

Access to resources Recommend Favorite

A Meta-Analysis of Randomized, Placebo-Controlled Clinical Trials of Efamol® Evening Primrose Oil in Atopic Eczema. Where Do We Go from Here in Light of More Recent Discoveries?

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 6, 2006-01 ,pp. : 503-524

Bentham Science Publishers

Access to resources Recommend Favorite

Profile of Adverse Events with Duloxetine Treatment: A Pooled Analysis of Placebo-Controlled Studies

By Brunton Stephen  

Drug Safety, Vol. 33, Iss. 5, 2010-05 ,pp. : 393-407

Adis International

Access to resources Recommend Favorite